Results 241 to 250 of about 258,969 (413)

Oral Immunotherapy in Peanut‐Allergic Adults Using Real‐World Materials

open access: yesAllergy, EarlyView.
In 21 adults initiated on peanut oral immunotherapy (OIT), 67% tolerated at least 1000 mg on exit DBPCFC. Decreases in SPT size and increases in peanut‐ and Ara h 2‐specific IgG occurred in OIT participants but not in mechanistic controls (n = 9). Improvements were seen in FAQLQ‐AF and food neophobia scores.
Hannah Hunter   +10 more
wiley   +1 more source

Big Data-Driven Evolution of a Diagnostic Multiplex IgE-Test: Enhancing Accuracy and Efficacy in Allergy Diagnostics. [PDF]

open access: yesInt J Mol Sci
Lupinek C   +6 more
europepmc   +1 more source

Dual Inhibition of Mast Cells and Thymic Stromal Lymphopoietin Using a Novel Bispecific Antibody, CDX‐622

open access: yesAllergy, EarlyView.
SCF and TSLP expression are known to drive unique immune responses leading to the onset of allergic and inflammatory diseases. Here, we describe the characterization of a novel bsAb, CDX‐622, that targets SCF and TSLP. CDX‐622 inhibits MC functions through SCF starvation and Type 2 inflammatory responses via TSLP inhibition.
Michael B. Murphy   +17 more
wiley   +1 more source

Purification of Prudu6 from Almond and Its Cross-Reactivity with Glym6 from Soybean. [PDF]

open access: yesInt J Mol Sci
Hu C   +10 more
europepmc   +1 more source

Physiochemical and biologic properties of allergen extracted from cat pelts

open access: bronze, 1973
J OHMANJR   +2 more
openalex   +1 more source

Standardization of fungal allergens [PDF]

open access: bronze, 1987
Robert K. Bush, John W. Yunginger
openalex   +1 more source

IL‐1R2 Expression in Tfr Cells Controls Allergic Anaphylaxis by Regulating IgG Versus IgE Responses

open access: yes
Allergy, EarlyView.
Paul Engeroff   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy